IGF-1 is associated with estimated bone strength in anorexia nervosa

Area of Science:

• Endocrinology
• Bone Metabolism
• Nutritional Psychiatry

Background:

• Anorexia nervosa (AN) is a psychiatric disorder associated with impaired bone formation, low bone mass, and increased fracture risk.
• Nutritionally dependent hormones, including insulin-like growth factor 1 (IGF-1) and leptin, are implicated in low bone mass in women with AN.
• The relationship between these hormones and actual bone strength in AN remains to be fully elucidated.

Purpose of the Study:

• To investigate the association between serum levels of IGF-1 and leptin and estimated bone strength in women with anorexia nervosa.
• To compare these associations in women with AN versus normal-weight controls.

Main Methods:

• Cross-sectional study involving 38 women (19 with AN, 19 controls).
• Serum IGF-1 and leptin levels were measured.
• Finite element analysis of high-resolution peripheral quantitative CT images was used to estimate bone stiffness and failure load of the distal radius and tibia.

Main Results:

• IGF-1 showed a strong positive correlation with estimated bone strength (stiffness and failure load) in both the radius and tibia of women with AN.
• No significant association was found between leptin and estimated bone strength in women with AN or controls.
• IGF-1 was not significantly correlated with bone strength in normal-weight controls.

Conclusions:

• IGF-1 is a significant determinant of bone strength in the radius and tibia in women with anorexia nervosa.
• These findings suggest a potential therapeutic role for IGF-1 in improving bone health and reducing fracture risk in this population.
• Further research is warranted to explore the efficacy of recombinant human IGF-1 treatment.